全国生物医药园区50强江苏占17席

Core Insights - The 2025 China Biotechnology Innovation Conference opened in Chengdu, where the "2024 China Biopharmaceutical Park Competitiveness Evaluation and Analysis Report" was presented, highlighting the competitive landscape of biopharmaceutical parks in China [1] Group 1: Competitiveness Rankings - The "2024 China Biopharmaceutical Park Competitiveness Rankings" revealed that Jiangsu Province holds 17 out of the top 50 spots, an increase of 3 from the previous year [1] - The rankings assess biopharmaceutical parks based on multiple dimensions including environment, industry, technology, talent, and cooperation, making it one of the most authoritative evaluations of regional biopharmaceutical industry development [1] Group 2: Jiangsu Province Highlights - Suzhou Industrial Park continues to lead with a comprehensive competitiveness ranking of second nationally, following the Zhongguancun National Independent Innovation Demonstration Zone [1] - Suzhou's talent and cooperation competitiveness are ranked first nationally, solidifying its position in the top tier of biopharmaceutical parks [1] - The biopharmaceutical and health industry is a strategic emerging industry that Suzhou Industrial Park has consistently focused on since its establishment in 2006, with over 2,000 related enterprises and an expected output value of 165.5 billion yuan in 2024 [1] Group 3: Other Notable Parks - Jiangsu Province has three parks in the top 10, with Nanjing Biopharmaceutical Valley ranked 8th and Taizhou High-tech Pharmaceutical Industrial Development Zone ranked 10th [1]